Lung Cancer News and Research

Latest Lung Cancer News and Research

KU professor to create patient-friendly lung cancer treatment

KU professor to create patient-friendly lung cancer treatment

Helsinn begins enrollment in anamorelin Phase III trial for NSCLC-associated anorexia/cachexia

Helsinn begins enrollment in anamorelin Phase III trial for NSCLC-associated anorexia/cachexia

IsoRay Cs-131 mesh brachytherapy with da Vinci Robot for lung cancer treatment gains momentum

IsoRay Cs-131 mesh brachytherapy with da Vinci Robot for lung cancer treatment gains momentum

Johns Hopkins establishes Center for Personalized Cancer Medicine with Commonwealth Foundation gift

Johns Hopkins establishes Center for Personalized Cancer Medicine with Commonwealth Foundation gift

High cigarette price, economic factors appear to reduce smoking rates among African-American youth

High cigarette price, economic factors appear to reduce smoking rates among African-American youth

Scientists shed light on the dark secret of Queen Hatshepsut's deadly medication

Scientists shed light on the dark secret of Queen Hatshepsut's deadly medication

Scientists turn drug-disease match makers

Scientists turn drug-disease match makers

Lighter smokers with two high-risk gene variations more likely to develop lung cancer

Lighter smokers with two high-risk gene variations more likely to develop lung cancer

EMA accepts Pfizer's regulatory submissions of two investigational cancer drugs for review

EMA accepts Pfizer's regulatory submissions of two investigational cancer drugs for review

New research: Sniffer dogs can reliably identify lung cancer

New research: Sniffer dogs can reliably identify lung cancer

Syndax receives European patent allowance for entinostat to treat metastatic breast cancer

Syndax receives European patent allowance for entinostat to treat metastatic breast cancer

Debate emerges regarding benefit of CT scans for lung cancer

Debate emerges regarding benefit of CT scans for lung cancer

First Edition: August 16, 2011

First Edition: August 16, 2011

Pfizer, QIAGEN partner to develop diagnostic-therapeutic combination for NSCLC

Pfizer, QIAGEN partner to develop diagnostic-therapeutic combination for NSCLC

Survey: 35% of people in the UK fear cancer more than other life-threatening conditions

Survey: 35% of people in the UK fear cancer more than other life-threatening conditions

NSAIDs like ibuprofen slow the spread of breast cancers

NSAIDs like ibuprofen slow the spread of breast cancers

Women worst hit by smoking

Women worst hit by smoking

GTx reports revenue of $1.6 million for second quarter 2011

GTx reports revenue of $1.6 million for second quarter 2011

Smoking first thing in the morning ‘ups’ cancer stakes

Smoking first thing in the morning ‘ups’ cancer stakes

Response Genetics second quarter total revenue increases 18.8% to $6.7 million

Response Genetics second quarter total revenue increases 18.8% to $6.7 million

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.